Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

John Mitchell

Concepts (437)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pneumonectomy
40
2024
150
6.070
 Why?
Anesthesiology
11
2023
90
3.160
 Why?
Thoracic Surgery
16
2025
133
3.100
 Why?
Mycobacterium Infections, Nontuberculous
11
2024
364
3.080
 Why?
Esophageal Neoplasms
19
2025
317
2.760
 Why?
Lung Neoplasms
39
2024
2571
2.330
 Why?
Internship and Residency
16
2023
1173
2.190
 Why?
Clinical Competence
18
2023
1123
2.170
 Why?
Thoracic Surgical Procedures
13
2025
71
2.150
 Why?
Lung Diseases
9
2024
769
1.610
 Why?
Echocardiography, Transesophageal
7
2022
95
1.530
 Why?
Thoracic Surgery, Video-Assisted
11
2022
45
1.530
 Why?
Nontuberculous Mycobacteria
6
2024
205
1.520
 Why?
Esophagectomy
14
2024
125
1.450
 Why?
Anesthesiologists
2
2021
28
1.390
 Why?
Carcinoma, Non-Small-Cell Lung
16
2024
1110
1.380
 Why?
Educational Measurement
5
2023
290
1.370
 Why?
Education, Medical, Graduate
7
2023
485
1.280
 Why?
Postoperative Complications
27
2025
2671
1.270
 Why?
Anesthesia
5
2023
192
1.080
 Why?
Surgeons
7
2025
306
1.030
 Why?
Bronchiectasis
3
2012
110
0.990
 Why?
Tuberculosis, Pulmonary
3
2018
142
0.930
 Why?
Adenocarcinoma
8
2024
880
0.930
 Why?
Lung Transplantation
7
2019
314
0.910
 Why?
Empyema, Pleural
2
2015
11
0.890
 Why?
Robotic Surgical Procedures
6
2024
138
0.890
 Why?
Societies, Medical
10
2023
820
0.820
 Why?
Humans
142
2025
138102
0.800
 Why?
Neoplasm Staging
15
2024
1371
0.780
 Why?
Perioperative Care
4
2018
180
0.780
 Why?
Curriculum
7
2023
1003
0.770
 Why?
Central Venous Catheters
1
2022
51
0.710
 Why?
Catheterization, Central Venous
1
2022
113
0.650
 Why?
Ultrasonography, Interventional
2
2018
139
0.640
 Why?
Minimally Invasive Surgical Procedures
6
2024
174
0.640
 Why?
Teaching
3
2021
231
0.610
 Why?
Ischemic Preconditioning
3
2024
42
0.600
 Why?
Pleura
2
2024
23
0.540
 Why?
Practice Guidelines as Topic
6
2017
1557
0.530
 Why?
Thoracic Wall
1
2017
19
0.530
 Why?
Soft Tissue Infections
1
2017
38
0.520
 Why?
Abscess
1
2017
75
0.510
 Why?
Thoracoscopy
5
2020
54
0.510
 Why?
Bronchial Fistula
2
2015
4
0.500
 Why?
Respiratory Tract Fistula
2
2015
7
0.490
 Why?
Pleural Diseases
2
2015
23
0.490
 Why?
Tomography, X-Ray Computed
10
2018
2693
0.490
 Why?
Anastomosis, Surgical
3
2024
155
0.480
 Why?
Laparoscopy
4
2024
445
0.480
 Why?
Thoracotomy
6
2019
76
0.480
 Why?
Databases, Factual
13
2025
1381
0.470
 Why?
Pneumonia, Bacterial
2
2013
114
0.460
 Why?
Male
65
2025
67984
0.460
 Why?
Female
69
2025
73648
0.460
 Why?
Osteomyelitis
1
2017
134
0.460
 Why?
Computer Simulation
5
2021
987
0.440
 Why?
Middle Aged
51
2025
33509
0.430
 Why?
Computer-Assisted Instruction
1
2014
69
0.430
 Why?
Aged
41
2025
23995
0.410
 Why?
Chest Tubes
1
2013
29
0.410
 Why?
Physicians, Women
2
2025
83
0.410
 Why?
Equipment Contamination
1
2013
68
0.410
 Why?
Length of Stay
8
2024
1214
0.410
 Why?
Treatment Outcome
20
2025
10832
0.400
 Why?
Internet
2
2014
681
0.400
 Why?
Tracheobronchomalacia
1
2012
15
0.390
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2024
1702
0.380
 Why?
Retrospective Studies
27
2025
15750
0.370
 Why?
Anti-Bacterial Agents
6
2024
1804
0.370
 Why?
United States
24
2025
15028
0.360
 Why?
Tuberculosis, Multidrug-Resistant
1
2012
58
0.360
 Why?
Sputum
1
2013
304
0.350
 Why?
Coronary Artery Bypass
2
2015
231
0.340
 Why?
Pneumoperitoneum
1
2010
11
0.340
 Why?
Conversion to Open Surgery
2
2020
16
0.330
 Why?
Trachea
3
2022
249
0.330
 Why?
Prospective Studies
14
2024
7603
0.330
 Why?
Early Detection of Cancer
1
2015
461
0.320
 Why?
Combined Modality Therapy
6
2022
1234
0.320
 Why?
Mass Screening
2
2015
1303
0.310
 Why?
Simulation Training
2
2021
109
0.300
 Why?
Specialties, Surgical
2
2023
75
0.290
 Why?
Consensus
3
2021
676
0.290
 Why?
Heart Diseases
2
2022
331
0.280
 Why?
Cost of Illness
1
2010
303
0.280
 Why?
Small Cell Lung Carcinoma
2
2024
115
0.270
 Why?
Workflow
2
2021
164
0.270
 Why?
Mycobacterium avium-intracellulare Infection
1
2008
62
0.270
 Why?
Induction Chemotherapy
2
2024
78
0.260
 Why?
Pleural Neoplasms
2
2024
25
0.260
 Why?
Airway Obstruction
2
2022
157
0.250
 Why?
Diaphragm
2
2023
43
0.250
 Why?
Time-to-Treatment
2
2025
203
0.250
 Why?
Patient Satisfaction
1
2010
681
0.250
 Why?
Benchmarking
3
2023
186
0.240
 Why?
Postoperative Care
3
2012
265
0.240
 Why?
Esophageal Diseases
1
2006
29
0.240
 Why?
Anesthetics
2
2022
81
0.240
 Why?
Fever
1
2007
306
0.240
 Why?
Chemoradiotherapy
2
2024
229
0.240
 Why?
Diagnostic Techniques, Respiratory System
1
2005
5
0.240
 Why?
Thoracic Neoplasms
1
2005
36
0.230
 Why?
Prognosis
9
2024
3982
0.220
 Why?
Genes, Plant
1
2024
50
0.210
 Why?
Magnoliopsida
1
2024
33
0.210
 Why?
Patient Readmission
3
2019
702
0.210
 Why?
Preoperative Care
3
2012
354
0.210
 Why?
Esophagogastric Junction
3
2024
52
0.210
 Why?
Adult
28
2025
38063
0.210
 Why?
Esophageal Stenosis
1
2024
55
0.210
 Why?
Carcinoma, Bronchogenic
1
2003
20
0.200
 Why?
Respiratory Paralysis
1
2023
3
0.200
 Why?
Hypothermia
1
2023
37
0.200
 Why?
Aged, 80 and over
13
2024
7638
0.200
 Why?
Mentors
1
2025
211
0.200
 Why?
Plasmacytoma
1
2022
16
0.200
 Why?
Tracheal Neoplasms
1
2022
9
0.200
 Why?
Interleukin-6
1
2007
786
0.200
 Why?
Guideline Adherence
2
2024
557
0.200
 Why?
Bronchi
2
2007
267
0.190
 Why?
Neoplasm Recurrence, Local
4
2024
1052
0.190
 Why?
Neoplasms, Second Primary
1
2024
114
0.190
 Why?
Biomedical Research
2
2021
703
0.190
 Why?
Propensity Score
3
2019
307
0.190
 Why?
Ascites
1
2002
47
0.190
 Why?
Cardiovascular Diseases
4
2019
2121
0.190
 Why?
Patient Selection
5
2015
692
0.190
 Why?
Pleural Effusion
1
2002
55
0.180
 Why?
Neoadjuvant Therapy
5
2024
407
0.180
 Why?
Endometriosis
1
2002
50
0.180
 Why?
Pandemics
4
2025
1639
0.180
 Why?
Periodicals as Topic
1
2024
212
0.180
 Why?
Leukemia
1
2024
241
0.180
 Why?
Credentialing
1
2021
19
0.180
 Why?
Pain, Postoperative
2
2023
281
0.180
 Why?
Infectious Disease Transmission, Patient-to-Professional
1
2021
20
0.170
 Why?
Leadership
1
2025
394
0.170
 Why?
Interdisciplinary Research
1
2021
27
0.170
 Why?
Bronchoscopy
4
2012
218
0.170
 Why?
Sarcoma
1
2003
189
0.170
 Why?
Technology
1
2021
95
0.170
 Why?
Disease-Free Survival
4
2024
669
0.170
 Why?
Cardiovascular Abnormalities
1
2020
13
0.160
 Why?
Education, Distance
1
2021
53
0.160
 Why?
Subclavian Artery
1
2020
28
0.160
 Why?
Developing Countries
1
2022
312
0.160
 Why?
Carotid Artery, Common
1
2020
37
0.160
 Why?
Robotics
1
2021
85
0.160
 Why?
Evolution, Molecular
1
2024
518
0.160
 Why?
Phylogeny
1
2024
1009
0.160
 Why?
Anastomotic Leak
3
2024
41
0.160
 Why?
Survival Rate
5
2024
1912
0.150
 Why?
Stomach
3
2024
108
0.150
 Why?
Educational Status
1
2021
474
0.150
 Why?
General Surgery
1
2021
173
0.150
 Why?
Quality of Life
3
2024
2936
0.150
 Why?
Metastasectomy
1
2018
20
0.150
 Why?
Genomics
1
2024
807
0.150
 Why?
Feasibility Studies
3
2018
971
0.150
 Why?
Carcinoma, Squamous Cell
3
2012
647
0.140
 Why?
Manikins
1
2018
30
0.140
 Why?
Pulmonary Emphysema
2
2015
289
0.140
 Why?
Anesthesia, Cardiac Procedures
1
2017
6
0.140
 Why?
Cohort Studies
5
2019
5731
0.140
 Why?
Forms and Records Control
1
2017
21
0.130
 Why?
Negative-Pressure Wound Therapy
1
2017
29
0.130
 Why?
Pylorus
1
2017
18
0.130
 Why?
Gastric Outlet Obstruction
1
2017
12
0.130
 Why?
Learning
1
2021
416
0.130
 Why?
Pain Management
1
2020
365
0.130
 Why?
Clinical Protocols
3
2024
267
0.130
 Why?
Frailty
1
2019
173
0.120
 Why?
Neuromuscular Agents
1
2017
39
0.120
 Why?
NADPH Oxidases
1
2017
139
0.120
 Why?
Antigen Presentation
1
2017
220
0.120
 Why?
CD4-Positive T-Lymphocytes
2
2017
1101
0.120
 Why?
Botulinum Toxins, Type A
1
2017
50
0.120
 Why?
Faculty, Medical
1
2018
289
0.120
 Why?
Lymphocytes, Tumor-Infiltrating
1
2017
206
0.120
 Why?
Program Development
1
2017
367
0.120
 Why?
Extracorporeal Membrane Oxygenation
1
2019
309
0.120
 Why?
Cause of Death
1
2017
428
0.120
 Why?
Documentation
1
2017
199
0.110
 Why?
Patient-Centered Care
1
2020
541
0.110
 Why?
Asphyxia
1
2014
20
0.110
 Why?
Risk Factors
7
2024
10433
0.110
 Why?
Radiotherapy Dosage
1
2015
278
0.110
 Why?
Kidney Neoplasms
2
2009
402
0.110
 Why?
Chronic Disease
3
2017
1791
0.110
 Why?
Risk
2
2015
906
0.110
 Why?
Chemotherapy, Adjuvant
2
2005
373
0.110
 Why?
Pulmonary Disease, Chronic Obstructive
2
2015
1029
0.110
 Why?
Intubation, Intratracheal
1
2016
259
0.110
 Why?
Dyspnea
2
2023
251
0.100
 Why?
Suture Techniques
2
2006
120
0.100
 Why?
Diabetes Mellitus
1
2022
1059
0.100
 Why?
Myocardial Infarction
1
2021
1053
0.100
 Why?
Health Expenditures
1
2015
189
0.100
 Why?
Perfusion
1
2014
223
0.100
 Why?
Accreditation
2
2023
84
0.100
 Why?
Patient Discharge
1
2019
907
0.100
 Why?
Group II Phospholipases A2
1
2012
9
0.100
 Why?
Carcinoma, Large Cell
1
2012
15
0.100
 Why?
Extensively Drug-Resistant Tuberculosis
1
2012
6
0.100
 Why?
Mutation
3
2022
3994
0.100
 Why?
Cardiology
1
2015
274
0.100
 Why?
Consumer Health Information
1
2013
49
0.100
 Why?
Radiography
1
2014
846
0.090
 Why?
Ultrasonography
1
2016
774
0.090
 Why?
Time Factors
5
2024
6845
0.090
 Why?
Cost-Benefit Analysis
1
2015
585
0.090
 Why?
B-Lymphocytes
1
2017
849
0.090
 Why?
Volatile Organic Compounds
1
2012
62
0.090
 Why?
Tracheal Stenosis
1
2012
31
0.090
 Why?
ErbB Receptors
2
2022
609
0.090
 Why?
ras Proteins
1
2012
150
0.090
 Why?
Cardiac Surgical Procedures
2
2017
538
0.090
 Why?
Logistic Models
4
2019
2081
0.090
 Why?
Physician's Role
1
2013
219
0.090
 Why?
Risk Assessment
4
2023
3471
0.090
 Why?
Atrial Flutter
1
2011
30
0.080
 Why?
Smoking
2
2017
1616
0.080
 Why?
Morbidity
3
2023
322
0.080
 Why?
Mycobacterium Infections
1
2011
62
0.080
 Why?
Antitubercular Agents
1
2012
204
0.080
 Why?
Tissue and Organ Procurement
1
2014
318
0.080
 Why?
Quality Improvement
4
2020
1184
0.080
 Why?
Hemoptysis
1
2010
36
0.080
 Why?
Oxidative Stress
1
2017
1322
0.080
 Why?
Syndrome
1
2011
377
0.080
 Why?
Patient Reported Outcome Measures
2
2024
404
0.080
 Why?
Hospital Costs
1
2010
116
0.080
 Why?
Mycobacterium
1
2011
110
0.080
 Why?
Neoplasm Invasiveness
3
2024
498
0.080
 Why?
Carcinoma, Papillary
1
2009
71
0.080
 Why?
DNA-Binding Proteins
1
2017
1477
0.080
 Why?
Follow-Up Studies
3
2024
5144
0.080
 Why?
Teratoma
1
2010
118
0.080
 Why?
Proto-Oncogene Proteins
1
2012
624
0.080
 Why?
Kaplan-Meier Estimate
2
2023
878
0.070
 Why?
Enzyme Inhibitors
1
2012
847
0.070
 Why?
Reoperation
2
2008
579
0.070
 Why?
Lymph Nodes
2
2023
493
0.070
 Why?
Transcription Factors
1
2017
1709
0.070
 Why?
Registries
1
2016
2059
0.070
 Why?
Carcinoid Tumor
1
2008
23
0.070
 Why?
Intraoperative Care
1
2008
58
0.070
 Why?
Mountaineering
1
2008
40
0.070
 Why?
Stents
1
2012
523
0.070
 Why?
Positron-Emission Tomography
2
2009
294
0.070
 Why?
Vena Cava, Inferior
1
2008
69
0.070
 Why?
Heart Failure
1
2021
2050
0.070
 Why?
Multivariate Analysis
3
2019
1495
0.070
 Why?
Spectral Karyotyping
1
2007
5
0.070
 Why?
Thrombectomy
1
2008
73
0.070
 Why?
Neoplasm, Residual
1
2008
133
0.070
 Why?
Li-Fraumeni Syndrome
1
2007
14
0.070
 Why?
Respiratory Sounds
1
2008
109
0.070
 Why?
Nephrectomy
1
2008
159
0.070
 Why?
Atrial Fibrillation
1
2011
378
0.070
 Why?
Barrett Esophagus
1
2009
150
0.070
 Why?
Renal Dialysis
1
2011
434
0.060
 Why?
Surgical Flaps
1
2008
141
0.060
 Why?
Pyrimidines
1
2010
467
0.060
 Why?
Chromosome Aberrations
1
2007
157
0.060
 Why?
Reproducibility of Results
3
2023
3301
0.060
 Why?
Urinary Bladder Neoplasms
1
2009
261
0.060
 Why?
Sulfonamides
1
2010
510
0.060
 Why?
Carbonic Anhydrases
1
2006
14
0.060
 Why?
Vascular Surgical Procedures
1
2009
310
0.060
 Why?
Mediastinoscopy
1
2005
5
0.060
 Why?
Fatigue
2
2023
338
0.060
 Why?
Sialoglycoproteins
1
2006
159
0.060
 Why?
Precancerous Conditions
1
2007
166
0.060
 Why?
Hyaluronan Receptors
1
2006
103
0.060
 Why?
Carcinoma, Renal Cell
1
2008
219
0.060
 Why?
Delivery of Health Care
1
2013
964
0.060
 Why?
Decision Making
1
2013
941
0.060
 Why?
Insulin Infusion Systems
1
2009
397
0.060
 Why?
Blood Loss, Surgical
1
2005
99
0.060
 Why?
Hospital Mortality
2
2019
912
0.060
 Why?
Radiotherapy, Adjuvant
1
2005
214
0.050
 Why?
Heart-Lung Transplantation
1
2004
13
0.050
 Why?
Chylothorax
1
2004
17
0.050
 Why?
Odds Ratio
2
2019
1077
0.050
 Why?
Emergencies
1
2025
168
0.050
 Why?
Diagnosis, Differential
2
2010
1490
0.050
 Why?
Antineoplastic Agents
2
2012
2125
0.050
 Why?
Fossils
1
2024
75
0.050
 Why?
Cytogenetic Analysis
1
2003
33
0.050
 Why?
Apoptosis
1
2012
2555
0.050
 Why?
Antigens, Neoplasm
1
2006
317
0.050
 Why?
Biomarkers, Tumor
2
2007
1235
0.050
 Why?
Contraindications
1
2003
88
0.050
 Why?
Constriction, Pathologic
1
2024
238
0.050
 Why?
Evidence-Based Medicine
2
2017
743
0.050
 Why?
Mesoderm
1
2003
144
0.050
 Why?
Airway Management
1
2022
52
0.050
 Why?
Lung
4
2024
4065
0.050
 Why?
Advisory Committees
1
2023
221
0.050
 Why?
Cell Survival
2
2017
1130
0.040
 Why?
Sex Factors
1
2007
2071
0.040
 Why?
Operating Rooms
1
2022
125
0.040
 Why?
Oxygen
1
2006
955
0.040
 Why?
Learning Curve
1
2021
69
0.040
 Why?
Data Warehousing
1
2020
6
0.040
 Why?
Receptor Protein-Tyrosine Kinases
1
2022
231
0.040
 Why?
Case-Control Studies
2
2024
3569
0.040
 Why?
Socioeconomic Factors
1
2024
1312
0.040
 Why?
Intermediate Care Facilities
1
2019
4
0.040
 Why?
Gene Expression Regulation, Neoplastic
3
2012
1388
0.040
 Why?
Recurrence
1
2023
1073
0.040
 Why?
Survival Analysis
2
2017
1292
0.040
 Why?
Margins of Excision
1
2019
42
0.040
 Why?
Psychometrics
1
2023
724
0.040
 Why?
Imaging, Three-Dimensional
1
2003
564
0.040
 Why?
Walk Test
1
2019
78
0.040
 Why?
Nuclear Proteins
1
2024
709
0.040
 Why?
Cytokines
1
2007
2079
0.040
 Why?
Cross-Sectional Studies
2
2022
5556
0.040
 Why?
Serum Albumin
1
2019
150
0.040
 Why?
Insulin
1
2009
2405
0.040
 Why?
Radiography, Thoracic
2
2010
169
0.040
 Why?
Sarcopenia
1
2019
81
0.040
 Why?
Skilled Nursing Facilities
1
2019
141
0.030
 Why?
Qualitative Research
1
2025
1435
0.030
 Why?
Algorithms
1
2005
1711
0.030
 Why?
Lymphocyte Count
1
2017
150
0.030
 Why?
NADPH Oxidase 4
1
2017
8
0.030
 Why?
Patient Care Team
1
2022
637
0.030
 Why?
Antigen-Presenting Cells
1
2017
158
0.030
 Why?
Glutathione Disulfide
1
2017
33
0.030
 Why?
Continuity of Patient Care
1
2019
282
0.030
 Why?
Regression Analysis
1
2019
1012
0.030
 Why?
Gastric Emptying
1
2017
36
0.030
 Why?
Geography
1
2017
204
0.030
 Why?
Incidence
1
2023
2827
0.030
 Why?
Gastroepiploic Artery
1
2015
4
0.030
 Why?
Immunophenotyping
1
2017
324
0.030
 Why?
Home Care Services
1
2019
259
0.030
 Why?
Superoxides
1
2017
217
0.030
 Why?
Mammary Arteries
1
2015
7
0.030
 Why?
Cytoplasm
1
2017
267
0.030
 Why?
Inflammation
1
2007
2847
0.030
 Why?
Academic Medical Centers
1
2018
506
0.030
 Why?
Writing
1
2017
99
0.030
 Why?
Radial Artery
1
2015
70
0.030
 Why?
Green Fluorescent Proteins
1
2017
396
0.030
 Why?
Task Performance and Analysis
1
2016
187
0.030
 Why?
Fluorescent Dyes
1
2017
318
0.030
 Why?
Adaptor Proteins, Signal Transducing
1
2017
430
0.030
 Why?
Focus Groups
1
2016
536
0.030
 Why?
Lymphocyte Activation
1
2017
1146
0.030
 Why?
Tumor Microenvironment
1
2017
668
0.030
 Why?
Antioxidants
1
2017
588
0.020
 Why?
Oxidation-Reduction
1
2017
1075
0.020
 Why?
Solid Phase Microextraction
1
2012
9
0.020
 Why?
Young Adult
3
2014
13329
0.020
 Why?
Breath Tests
1
2012
75
0.020
 Why?
Gas Chromatography-Mass Spectrometry
1
2012
134
0.020
 Why?
Gastroscopy
1
2012
18
0.020
 Why?
Silicones
1
2012
25
0.020
 Why?
Foreign-Body Migration
1
2012
33
0.020
 Why?
Biomechanical Phenomena
1
2015
815
0.020
 Why?
Analgesics, Opioid
1
2020
1049
0.020
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2012
174
0.020
 Why?
Fibroblasts
1
2017
1002
0.020
 Why?
Gene Expression Regulation, Enzymologic
1
2012
276
0.020
 Why?
Proto-Oncogene Proteins p21(ras)
1
2012
263
0.020
 Why?
Lymphatic Metastasis
1
2012
322
0.020
 Why?
Gene Expression Profiling
2
2010
1755
0.020
 Why?
Forced Expiratory Volume
1
2012
481
0.020
 Why?
Device Removal
1
2012
135
0.020
 Why?
Debridement
1
2011
83
0.020
 Why?
False Positive Reactions
1
2011
124
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2012
979
0.020
 Why?
Artifacts
1
2011
129
0.020
 Why?
Air
1
2010
41
0.020
 Why?
Global Health
1
2013
384
0.020
 Why?
Indazoles
1
2010
68
0.020
 Why?
Adolescent
3
2014
21637
0.020
 Why?
Blotting, Western
1
2012
1223
0.020
 Why?
Chest Pain
1
2010
93
0.020
 Why?
Mice, Knockout
1
2017
3014
0.020
 Why?
Surveys and Questionnaires
1
2022
5850
0.020
 Why?
Molecular Targeted Therapy
1
2012
407
0.020
 Why?
Diarrhea
1
2010
184
0.020
 Why?
Photochemotherapy
1
2009
39
0.020
 Why?
Attitude of Health Personnel
1
2017
1157
0.020
 Why?
NF-kappa B
1
2012
679
0.020
 Why?
Drug Administration Schedule
1
2010
753
0.020
 Why?
Dose-Response Relationship, Drug
1
2012
2022
0.020
 Why?
Phosphorylation
1
2012
1760
0.020
 Why?
Administration, Oral
1
2010
786
0.020
 Why?
Cisplatin
1
2009
326
0.020
 Why?
Esophagoscopy
1
2009
210
0.020
 Why?
Electrocardiography
1
2011
611
0.020
 Why?
Gene Expression Regulation
1
2017
2586
0.020
 Why?
Decompression, Surgical
1
2008
109
0.020
 Why?
Pilot Projects
1
2012
1751
0.020
 Why?
Suicide
1
2014
660
0.020
 Why?
Carbonic Anhydrase IX
1
2006
4
0.020
 Why?
In Situ Hybridization, Fluorescence
1
2007
309
0.020
 Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2006
19
0.020
 Why?
Osteopontin
1
2006
32
0.020
 Why?
Biomarkers
1
2017
4111
0.020
 Why?
Tegafur
1
2005
6
0.020
 Why?
Platinum Compounds
1
2005
10
0.020
 Why?
Uracil
1
2005
31
0.020
 Why?
Lymphatic Diseases
1
2005
22
0.020
 Why?
Tracheal Diseases
1
2005
16
0.010
 Why?
Population Surveillance
1
2009
487
0.010
 Why?
Catheter Ablation
1
2009
330
0.010
 Why?
Biopsy
1
2009
1089
0.010
 Why?
Mediastinal Neoplasms
1
2005
48
0.010
 Why?
Drainage
1
2006
173
0.010
 Why?
Kidney Failure, Chronic
1
2011
572
0.010
 Why?
Clone Cells
1
2005
263
0.010
 Why?
Age Factors
1
2012
3285
0.010
 Why?
Lymphoma, Non-Hodgkin
1
2005
86
0.010
 Why?
Meta-Analysis as Topic
1
2005
186
0.010
 Why?
Cell Line, Tumor
1
2012
3404
0.010
 Why?
RNA, Messenger
1
2012
2799
0.010
 Why?
Respiratory Mucosa
1
2007
320
0.010
 Why?
Aminocaproates
1
2004
2
0.010
 Why?
Decision Trees
1
2004
88
0.010
 Why?
Oligonucleotide Array Sequence Analysis
1
2006
758
0.010
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2005
335
0.010
 Why?
Mediastinum
1
2002
22
0.010
 Why?
Sensitivity and Specificity
1
2007
1946
0.010
 Why?
Lymph Node Excision
1
2002
168
0.010
 Why?
Hypertension
1
2010
1310
0.010
 Why?
Clinical Trials as Topic
1
2005
1032
0.010
 Why?
Cells, Cultured
1
2007
4160
0.010
 Why?
Blood Glucose
1
2009
2198
0.010
 Why?
Animals
1
2017
37151
0.010
 Why?
Mitchell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (437) concept(s)
_
Co-Authors Expand Description
See all (70) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)